Drug Discovery Services Global Market Report 2025

Description

Drug discovery services involve the process of identifying potential new medicines, utilizing a combination of scientific disciplines such as biology, chemistry, and pharmacology. These services are structured across four stage such as early drug discovery, pre-clinical phase, clinical phases, and regulatory approval.

The primary types of drug discovery services include chemistry services and biology services. Chemistry services focus on the design and synthesis of biologically active molecules, aiming to discover and optimize chemical compounds for drug development. This involves the utilization of technologies like high-performance liquid chromatography and high-field NMR for the quick and efficient synthesis, analysis, and purification of compound libraries. Key processes within chemistry services include target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation, incorporating various drug types such as biologics and small molecules. End-users of drug discovery services encompass pharmaceutical and biotechnology companies, academic institutes, and other entities involved in the drug discovery process.

The drug discovery services market research report is one of a series of new reports from The Business Research Company that provides drug discovery services market statistics, including drug discovery services industry global market size, regional shares, competitors with a drug discovery services market share, detailed drug discovery services market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery services industry. This drug discovery services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug discovery services market size has grown rapidly in recent years. It will grow from $18.27 billion in 2024 to $20.59 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increased R&D investment, expanding disease burden, government funding and support, emergence of contract research organizations (CROs), shift towards personalized medicine, drug repurposing strategies.

The drug discovery services market size is expected to see rapid growth in the next few years. It will grow to $33.88 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to regulatory framework changes, advancements in drug delivery systems, increasing interest in immunotherapy, shift towards RNA-based therapeutics, targeting rare diseases. Major trends in the forecast period include advanced technologies adoption, biologicals and biopharmaceuticals growth, adoption of high-throughput screening, advancements in virtual screening, regenerative medicine focus.

The rising emphasis on drug discovery trials is anticipated to boost the drug discovery services market. The drug development life cycle plays a crucial role in ensuring the safe and effective delivery of medications. As a result, clinical trials are becoming increasingly important as a fundamental aspect of drug development. With the growing significance of drug development and innovation in healthcare, the demand for drug discovery trials has surged globally. For example, in May 2023, ClinicalTrials.gov, a platform for registering clinical trials, reported a total of 452,604 clinical trials in 2023, up from 365,000 registered trials in 2021. Therefore, the increasing focus on drug discovery trials is expected to drive the growth of the drug discovery services market.

The drug discovery services market is anticipated to witness growth driven by the rising prevalence of chronic diseases. Chronic diseases, characterized by long-lasting health conditions, necessitate ongoing management. Drug discovery services play a pivotal role in identifying and developing new medications for the treatment of chronic diseases. According to the National Library of Medicine, the US is expected to experience a 99.5% increase in the number of individuals aged 50 and older with at least one chronic condition, reaching 142.66 million by 2050. This increase in chronic diseases is poised to contribute significantly to the growth of the drug discovery services market.

Major companies in the drug discovery services market are developing advanced technologies, such as artificial intelligence (AI) and machine learning (ML), to improve the efficiency and accuracy of the drug discovery process. AI involves creating computer systems that can perform tasks typically requiring human intelligence, while ML, a subset of AI, focuses on using algorithms and statistical models to enable computers to learn from data and make predictions or decisions. For example, in February 2024, Eurofins Discovery, a France-based company providing support services across various sectors, including pharmaceuticals, announced the launch of an innovative platform called DiscoveryAI SAFIRE (Suite of ADMET Predictions for In Silico Refinement and Evaluation). This cutting-edge platform employs proprietary datasets, AI, and ML to enhance the drug discovery process. SAFIRE aims to accelerate the discovery of new pharmaceuticals by predicting the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties of molecules. The platform utilizes data from Eurofins Discovery's extensive BioPrint database, meticulously curated over years of research.

Major companies within the drug discovery services market are concentrating on product innovations and developing new solutions through process visualization and centralized data management to enhance their market position. The biodrug design accelerator platform is intended to assist peptide drug discovery scientists in pharmaceutical companies by increasing the efficiency of peptide drug development, specifically through the cycles of 'design, make, test, analyze' (DMTA). For instance, in May 2023, Fujitsu, a Japan-based multinational corporation specializing in information and communications technology equipment and services, introduced the biodrug design accelerator platform to expedite peptide drug discovery research. This initiative aims to facilitate faster and more efficient drug discovery through process visualization and centralized data management. The platform helps peptide designers visualize amino acid sequences for each peptide while organizing research results systematically. It is designed to manage research processes for peptide drug discovery, which is regarded as a promising area in the field of new drug development.

In January 2023, Sygnature Discovery, a prominent UK-based integrated Drug Discovery firm, successfully concluded the acquisition of SB Drug Discovery for an undisclosed sum. This strategic move is expected to provide mutual strategic advantages, facilitating the expansion of both companies and enhancing their respective capabilities. The acquisition aligns with Sygnature's strategic plan, demonstrating a commitment to ongoing investment in the expansion of its leading integrated drug discovery solutions. SB Drug Discovery, the acquired company, is a UK-based entity specializing in providing crucial data for novel drug development through services such as cell line generation, assay development, and compound screening.

Major companies operating in the drug discovery services market are Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., Bristol-Myers Squibb Company

North America was the largest region in the drug discovery services market in 2024. The regions covered in the drug discovery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug discovery services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug discovery services market includes revenues earned by entities by providing pharmaceutical services, drug metabolism and pharmacokinetics (DMPK) services, biological services, and medicinal chemistry. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Discovery Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug discovery services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug discovery services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug discovery services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Chemistry Services; Biology Services
2) By Process: Target Selection; Target Validation; Hit-To-Lead identification; Lead Optimization; Candidate Validation
3) By Drug Type: Biologics Drug ; Small Molecule Drug
4) By End user: Pharmaceutical And Biotechnology Companies; Academic Institutes; Other End Users
Subsegments:
1) By Chemistry Services: Medicinal Chemistry; Compound Management; High-Throughput Screening; Lead Optimization
2) By Biology Services: In Vitro Studies; In Vivo Studies; Pharmacokinetics And Pharmacodynamics (PK Or PD); Biomarker Discovery
Companies Mentioned: Thermo Fisher Scientific Inc.; Albany Molecular Research Inc.; Charles River Laboratories International Inc.; Laboratory Corporation of America Holdings; Domainex Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r22556

1. Executive Summary

2. Drug Discovery Services Market Characteristics

3. Drug Discovery Services Market Trends And Strategies

4. Drug Discovery Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Drug Discovery Services Growth Analysis And Strategic Analysis Framework

5.1. Global Drug Discovery Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Drug Discovery Services Market Growth Rate Analysis
5.4. Global Drug Discovery Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Drug Discovery Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Drug Discovery Services Total Addressable Market (TAM)

6. Drug Discovery Services Market Segmentation

6.1. Global Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chemistry Services
Biology Services
6.2. Global Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Target Selection
Target Validation
Hit-To-Lead identification
Lead Optimization
Candidate Validation
6.3. Global Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biologics Drug
Small Molecule Drug
6.4. Global Drug Discovery Services Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic Institutes
Other End Users
6.5. Global Drug Discovery Services Market, Sub-Segmentation Of Chemistry Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medicinal Chemistry
Compound Management
High-Throughput Screening
Lead Optimization
6.6. Global Drug Discovery Services Market, Sub-Segmentation Of Biology Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
In Vitro Studies
In Vivo Studies
Pharmacokinetics And Pharmacodynamics (PK Or PD)
Biomarker Discovery

7. Drug Discovery Services Market Regional And Country Analysis

7.1. Global Drug Discovery Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Drug Discovery Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Discovery Services Market

8.1. Asia-Pacific Drug Discovery Services Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Discovery Services Market

9.1. China Drug Discovery Services Market Overview
9.2. China Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Discovery Services Market

10.1. India Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Discovery Services Market

11.1. Japan Drug Discovery Services Market Overview
11.2. Japan Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Discovery Services Market

12.1. Australia Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Discovery Services Market

13.1. Indonesia Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Discovery Services Market

14.1. South Korea Drug Discovery Services Market Overview
14.2. South Korea Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Discovery Services Market

15.1. Western Europe Drug Discovery Services Market Overview
15.2. Western Europe Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Discovery Services Market

16.1. UK Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Discovery Services Market

17.1. Germany Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Discovery Services Market

18.1. France Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Discovery Services Market

19.1. Italy Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Discovery Services Market

20.1. Spain Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Discovery Services Market

21.1. Eastern Europe Drug Discovery Services Market Overview
21.2. Eastern Europe Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Discovery Services Market

22.1. Russia Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Discovery Services Market

23.1. North America Drug Discovery Services Market Overview
23.2. North America Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Discovery Services Market

24.1. USA Drug Discovery Services Market Overview
24.2. USA Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Discovery Services Market

25.1. Canada Drug Discovery Services Market Overview
25.2. Canada Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Discovery Services Market

26.1. South America Drug Discovery Services Market Overview
26.2. South America Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Discovery Services Market

27.1. Brazil Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Discovery Services Market

28.1. Middle East Drug Discovery Services Market Overview
28.2. Middle East Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Discovery Services Market

29.1. Africa Drug Discovery Services Market Overview
29.2. Africa Drug Discovery Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Drug Discovery Services Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Drug Discovery Services Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Discovery Services Market Competitive Landscape And Company Profiles

30.1. Drug Discovery Services Market Competitive Landscape
30.2. Drug Discovery Services Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Albany Molecular Research Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Domainex Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Drug Discovery Services Market Other Major And Innovative Companies

31.1. GenScript Biotech Corporation
31.2. Pharmaceutical Product Development LLC
31.3. Advinus Therapeutics Pvt. Ltd.
31.4. Jubilant Biosys Ltd.
31.5. Evotec AG
31.6. Syngene International Ltd.
31.7. Bayer AG
31.8. Merck KGaA
31.9. Ubiquigent Ltd.
31.10. Eurofins Scientific SE
31.11. AppTec Laboratory Services Inc.
31.12. GVK Biosciences Private Limited
31.13. Aurigene Discovery Technologies Limited
31.14. Viva Biotech Holdings
31.15. Pharmaron Beijing Co. Ltd.

32. Global Drug Discovery Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Discovery Services Market

34. Recent Developments In The Drug Discovery Services Market

35. Drug Discovery Services Market High Potential Countries, Segments and Strategies

35.1 Drug Discovery Services Market In 2029 - Countries Offering Most New Opportunities
35.2 Drug Discovery Services Market In 2029 - Segments Offering Most New Opportunities
35.3 Drug Discovery Services Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer